Skip to content

Birmingham Access to Care Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02525146
Acronym
BA2C
Enrollment
170
Registered
2015-08-17
Start date
2013-09-30
Completion date
2016-03-31
Last updated
2016-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Care Loss to Followup, HIV Infection

Keywords

HIV, Reengagement in HIV Care, ARTAS

Brief summary

The purpose of this study is to determine whether a modified form of the ARTAS (Antiretroviral Treatment and Access to Services) intervention, adapted for HIV patients who have fallen out of care, can be successful in re-engaging patients in care and reducing HIV-1 viral load.

Interventions

OTHERModified ARTAS (Antiretroviral Treatment and Access to Services) intervention

Sponsors

Birmingham AIDS Outreach
CollaboratorUNKNOWN
Johns Hopkins University
CollaboratorOTHER
AIDS United
CollaboratorUNKNOWN
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HIV patient with at least one primary care appointment since 1/1/10 but currently lost to follow-up defined as 1) currently out of care for greater than 7 months or 2) does NOT have two or more completed clinic visits separated by three or more months in time during a 12-month observation period (HRSA-HAB measure of retention in care) or 3) has 2 or more no shows - scheduled visits for which the patient has not arrived or canceled - in the past 12 months. * 19 years or older * Be able and willing to provide informed consent * Be willing to provide locator information * Be willing to sign a HIPAA authorization form/medical record release form to facilitate medical record abstraction * Report living in the vicinity * Be able to communicate in English.

Exclusion criteria

* Not meeting one of the above inclusion criteria * Have significant cognitive or developmental impairment to the extent that they are unable to provide informed consent * Incarcerated at the time of potential enrollment * Are terminated via site PI decision

Design outcomes

Primary

MeasureTime frameDescription
Change in HIV-1 Viral Load from Baseline to 12-month FollowupBaseline and 12-month FollowupHIV-1 viral load is obtained via study-specific lab work done at Baseline and at the 12-month followup session.

Secondary

MeasureTime frameDescription
Re-Engagement in Care: Post-Enrollment Linkage Visit + Meeting HRSA-HAB Guidelines for Retention in Care12-monthUsing HIV primary care clinic attendance records, participants are assessed as to 1) whether or not an HIV Primary Care visit was completed post study enrollment and 2) following that visit, whether the participant made and kept appointments as necessary to meet HRSA-HAB guidelines constituting retention in HIV care. BOTH conditions must be present in order for participant to be considered re-engaged in care.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026